Fractyl Health (GUTS) Financials: Revenue & Earnings

GUTS price $0.90 +0.02 +2.27%

Ticker
GUTS
Price
$0.90
Change
+0.02 +2.27%
Market cap ?
$11.94M
Beta ?
2.42
Sector
Healthcare
Industry
Biotechnology

Fair value

GUTS fair value $70.15. Price $0.90. Price is 99% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 12.03K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 13.26M. Net debt -19.89M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare GUTS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-1.59——
2026-08-11-1.92-1.62——
2026-05-13-0.13-0.17——
2026-03-24-2.04-2.28——
2025-11-12-0.71-4.08——
2025-08-13-4.20-4.44——
2025-05-12-0.47-5.40——
2025-04-07-0.52-5.283.00K10.00K
2024-11-13-5.76-6.0014.00K10.00K
2024-08-12-4.32-5.5243.00K—
2024-07-01-2.04-3.6033.00K—
2024-04-01-1.34-0.087.00K—
2023-12-14-7.44—36.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-14BRADLEY WILLIAMBuy64.52K$0.6239.90K
2026-06-12Royan AjayBuy23.00K$0.8519.60K
2026-06-10BRADLEY WILLIAMBuy68.49K$0.7350.33K
2026-06-10BRADLEY WILLIAMBuy22.50K$0.7316.47K
2026-06-10Conaway SamuelBuy22.50K$0.7316.47K
2026-06-10Royan AjayBuy22.50K$0.7316.47K
2026-06-10Thompson Christopher CharlesBuy22.50K$0.7316.47K
2026-06-10Elia MarcBuy22.50K$0.7316.47K
2026-06-10Barnes Kelly AnnBuy22.50K$0.7316.47K
2026-06-10MEANWELL CLIVEBuy22.50K$0.7316.47K
2026-06-10Sheffield IanBuy35.00K$0.7325.53K
2026-06-10Sheffield IanBuy22.50K$0.7316.47K
2026-06-10Rajagopalan HarithBuy25.00K$0.7318.25K
2026-06-08Smith Weber LaraBuy20.00K$0.6913.71K
2026-01-12Smith Weber LaraBuy1.04M$2.002.07M
2026-01-12Smith Weber LaraOther0——
2025-12-15Toomey SarahBuy743.91K$2.241.67M
2025-12-15Caplan Jay DavidBuy845.23K$2.241.89M
2025-12-15Rajagopalan HarithBuy2.49M$2.245.57M
2025-12-04Rajagopalan HarithBuy10.42K$1.9220.00K
2025-09-02Thompson Christopher CharlesBuy45.00K$0.9843.95K
2025-09-02Thompson Christopher CharlesOther20.97K$2.6755.99K
2025-09-02Sheffield IanBuy45.00K$0.9843.95K
2025-09-02Sheffield IanOther0——
2025-06-11SCHULMAN AMY WBuy22.50K$2.2751.08K
2025-06-11Elia MarcBuy22.50K$2.2751.08K
2025-06-11MEANWELL CLIVEBuy22.50K$2.2751.08K
2025-06-11BRADLEY WILLIAMBuy22.50K$2.2751.08K
2025-06-11Barnes Kelly AnnBuy22.50K$2.2751.08K
2025-06-11Royan AjayBuy22.50K$2.2751.08K
2025-06-11Conaway SamuelBuy22.50K$2.2751.08K
2025-03-14Royan AjayBuy17.90K$1.2822.98K
2025-03-14Barnes Kelly AnnBuy31.00K$1.3040.21K
2025-03-13Conaway SamuelOther0——
2025-03-13SCHULMAN AMY WBuy8.55K$1.179.96K
2025-03-13BRADLEY WILLIAMBuy16.13K$1.2620.36K
2025-03-13Conaway SamuelBuy8.55K$1.179.96K
2025-02-27Kieffer TimothyBuy169.70K$1.46247.76K
2025-02-27Kieffer TimothyBuy35.28K$15.00529.20K
2025-02-27Toomey SarahBuy166.20K$1.46242.65K
2025-02-27Toomey SarahBuy79.38K$15.001.19M
2025-02-27Davidson LisaBuy174.70K$1.46255.06K
2025-02-27Davidson LisaBuy91.50K$15.001.37M
2025-02-27Caplan Jay DavidBuy179.70K$1.46262.36K
2025-02-27Caplan Jay DavidBuy104.40K$15.001.57M
2025-02-27Rajagopalan HarithBuy571.49K$1.46834.38K
2025-02-27Rajagopalan HarithBuy261.54K$15.003.92M
2025-01-31Rajagopalan HarithBuy90.97K$1.70154.65K
2025-01-31Rajagopalan HarithSell90.97K$1.82165.21K
2025-01-31Rajagopalan HarithSell90.97K$1.70154.65K
2025-01-31Caplan Jay DavidBuy22.35K$1.7037.99K
2025-01-31Caplan Jay DavidSell22.35K$1.8140.46K
2025-01-31Caplan Jay DavidSell22.35K$1.7037.99K
2025-01-30Rajagopalan HarithBuy20.95K$1.7035.61K
2025-01-30Rajagopalan HarithSell20.95K$1.9540.80K
2025-01-30Rajagopalan HarithSell20.95K$1.7035.61K
2025-01-30Caplan Jay DavidBuy21.47K$1.7036.50K
2025-01-30Caplan Jay DavidSell21.47K$1.9541.80K
2025-01-30Caplan Jay DavidSell21.47K$1.7036.50K
2024-11-11Rajagopalan HarithSell96.52K$2.47238.36K
2024-11-11Caplan Jay DavidSell64.20K$2.47158.54K
2024-11-10Rajagopalan HarithBuy216.92K——
2024-11-10Rajagopalan HarithSell216.92K——
2024-11-10Caplan Jay DavidBuy187.26K——
2024-11-10Caplan Jay DavidSell187.26K——
2024-09-12Caplan Jay DavidBuy95.48K$1.70162.32K
2024-09-12Caplan Jay DavidSell65.00K$2.90188.47K
2024-09-12Caplan Jay DavidSell95.48K$1.70162.32K
2024-04-01Kimber AdrianBuy250.00K$7.451.86M
2024-04-01Kimber AdrianOther0——
2024-02-06Bessemer Venture Partners VII L.P.Buy4.77M——
2024-02-06Bessemer Venture Partners VII L.P.Sell3.16M——
2024-02-06Bessemer Venture Partners VII L.P.Sell909.00K——
2024-02-06Bessemer Venture Partners VII L.P.Sell2.24M——
2024-02-06Bessemer Venture Partners VII L.P.Sell352.16K——
2024-02-06Bessemer Venture Partners VII L.P.Sell1.63M——
2024-02-06Bessemer Venture Partners VII L.P.Sell1.95M——
2024-02-06AMERICAN INTERNATIONAL GROUP, INC.Buy673.39K——
2024-02-06AMERICAN INTERNATIONAL GROUP, INC.Buy283.88K——
2024-02-06AMERICAN INTERNATIONAL GROUP, INC.Buy199.26K——
2024-02-06AMERICAN INTERNATIONAL GROUP, INC.Buy182.74K——
2024-02-06AMERICAN INTERNATIONAL GROUP, INC.Sell346.87K——
2024-02-06AMERICAN INTERNATIONAL GROUP, INC.Sell80.74K——
2024-02-06Corebridge DECO II, LLCBuy673.39K——
2024-02-06Corebridge DECO II, LLCSell1.17M——
2024-02-06Corebridge DECO II, LLCSell272.86K——
2024-02-06AMERICAN HOME ASSURANCE COBuy283.88K——
2024-02-06AMERICAN HOME ASSURANCE COSell494.17K——
2024-02-06AMERICAN HOME ASSURANCE COSell115.03K——
2024-02-06MEANWELL CLIVEBuy277.89K——
2024-02-06MEANWELL CLIVESell596.35K——
2024-02-06Royan AjayBuy5.16M——
2024-02-06Royan AjayBuy333.33K$15.005.00M
2024-02-06Royan AjayBuy918.57K——
2024-02-06Royan AjaySell545.45K——
2024-02-06Royan AjaySell373.02K——
2024-02-06Royan AjaySell1.60M——
2024-02-06Royan AjaySell6.50M——
2024-02-06Royan AjaySell4.03M——
2024-02-06Caplan Jay DavidBuy23.30K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 76, holders -7 vs prior quarter. Ownership 44.65%.

HolderSharesChangeChange %Value
NANTAHALA CAPITAL MANAGEMENT, LLC11.29M-2.08M-15.53%8.97M
CATALIO CAPITAL MANAGEMENT, LP6.17M676.88K+12.33%4.90M
VANGUARD CAPITAL MANAGEMENT LLC6.10M563.92K+10.19%4.84M
BANK OF AMERICA CORP /DE/6.03M5.91M+4727.74%4.79M
PALE FIRE CAPITAL SE5.00M-917.81K-15.50%3.97M
GENERAL CATALYST GROUP MANAGEMENT, LLC4.88M-7-0.00%3.88M
DEER MANAGEMENT CO. LLC4.77M00.00%3.79M
MAVERICK CAPITAL LTD3.97M00.00%3.16M
M28 CAPITAL MANAGEMENT LP1.86M00.00%1.47M
BLACKROCK, INC.1.80M-338.78K-15.83%1.43M
WOODLINE PARTNERS LP1.78M-458.09K-20.43%1.42M
JANE STREET GROUP, LLC1.73M1.69M+4260.78%1.38M
SILVERARC CAPITAL MANAGEMENT, LLC1.64M-63.65K-3.74%1.30M
UBS GROUP AG1.58M-42.27K-2.61%1.25M
CM MANAGEMENT, LLC1.40M00.00%1.11M
GEODE CAPITAL MANAGEMENT, LLC1.32M-118.92K-8.29%1.05M
IKARIAN CAPITAL, LLC1.10M00.00%873.84K
MARSHALL WACE, LLP1.08M272.87K+33.78%853.73K
LOGOS GLOBAL MANAGEMENT LP1.00M00.00%794.40K
BREVAN HOWARD CAPITAL MANAGEMENT LP916.32K683.95K+294.34%719.27K
683 CAPITAL MANAGEMENT, LLC756.72K-5.97M-88.75%601.13K
VANGUARD FIDUCIARY TRUST CO722.13K115.95K+19.13%573.37K
STATE STREET CORP516.00K51.30K+11.04%409.91K
MORGAN STANLEY426.50K-69.40K-13.99%338.81K
MINK BROOK ASSET MANAGEMENT LLC352.75K352.75KNew280.22K

Earnings and financials

Fractyl Health, Inc. (GUTS) trades at $0.90, with a market cap of $11.94M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Fractyl Health (GUTS) Financials: Revenue & Earnings

GUTS$0.90+0.02 +2.27%

$11.94M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History